latentbrief
Back to news
General2h ago

Perceptic Raises $12 Million for AI Drug Development Platform

Fortune1 min brief

In brief

  • Perceptic emerged from stealth and announced a $12 million seed funding round.
  • The company is building an end-to-end AI platform for drug development.
  • The company's software is already being used by multiple top-tier pharmaceutical companies.
  • Perceptic says its system can compress scientific due diligence from weeks to hours.
  • Perceptic is targeting areas like scouting external assets and clinical trial design.
  • The company says its data foundation has produced a 50-fold increase in clinical data extractions.
  • Perceptic will continue to develop its AI platform to speed up drug discovery.

Terms in this brief

end-to-end AI platform
An integrated system that uses AI to handle all stages of a process from start to finish. In this case, Perceptic's platform is designed to streamline drug discovery by automating tasks like identifying potential drugs and designing clinical trials.

Read full story at Fortune

More briefs